CHINA-ANHUI-HEFEI-"ARTIFICIAL SUN"-INT'L JOINT EXPERIMENTS (CN)

CHINA-ANHUI-HEFEI-"ARTIFICIAL SUN"-INT'L JOINT EXPERIMENTS (CN)

(240204) -- HEFEI, Feb. 4, 2024 (Xinhua) -- Richard Pitts, leader of the Experiments and Plasma Operation Section of ITER, works at the EAST control room in Hefei, east China's Anhui Province, Jan. 24, 2024. TO GO WITH "China Focus: Int'l scientists conduct joint experiments with China's 'artificial sun' team" (Xinhua/Zhang Duan)

  • Product Code
  • ILEA002271356
  • Registered date
  • 2024/2/04 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 8256 × 5504 pixel
  • Resolution
  • dpi
  • Deployment size
  • 3.44(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    CHINA-JIANGSU-GRAVITON-LIKE PARTICLE-EXPERIMENTAL EVIDENCE (CN)

    CHINA-JIANGSU-GRAVITON-LIKE PARTICLE-EXPERIMENTAL EVIDENCE (CN)

    (240329) -- NANJING, March 29, 2024 (Xinhua) -- Du Lingjie, leader of an international research team and a professor at the School of Physics at Nanjing University, is pictured in Nanjing, east China's Jiangsu Province, March 28, 2024. TO GO WITH "Chinese scientists find first experimental evidence of graviton-like particle" (Photo by Li Jiahao/Xinhua)
      CHINA-SHAANXI-XI'AN-ANCIENT CHINESE EMPEROR-GENETIC PROFILE-COMPLETION (CN)

      CHINA-SHAANXI-XI'AN-ANCIENT CHINESE EMPEROR-GENETIC PROFILE-COMPLETION (CN)

      (240330) -- XI'AN, March 30, 2024 (Xinhua) -- Wen Shaoqing, an associate professor of the Institute of Archaeological Science of Fudan University, introduces archaeological achievements of the tomb of Emperor Wu of the Xianbei-led Northern Zhou Dynasty (557-581), during a press conference in Xi'an, northwest China's Shaanxi Province, March 28, 2024. A team of Chinese scientists have completed the genetic profile of an ancient Chinese ethnic minority emperor via genome analysis, according to local archaeologists on Thursday. TO GO WITH "China Focus: Scientists restore profile of ancient Chinese emperor through genetic analysis" (Xinhua/Li Yibo)
        (EyesOnSci)CHINA-AOI TECHNOLOGY-RESEARCHER-ENTREPRENEUR (CN)

        (EyesOnSci)CHINA-AOI TECHNOLOGY-RESEARCHER-ENTREPRENEUR (CN)

        (240224) -- BEIJING, Feb. 24, 2024 (Xinhua) -- Zhang Zhengtao (L) discusses the panel operation of an intelligent inspection device with his colleague at the headquarters of CASI Vision in Luoyang, central China's Henan Province, Feb. 3, 2024. Led by his supervisor, Zhang Zhengtao, a graduate from the Institute of Automation of the Chinese Academy of Sciences (CASIA), joined the research of a large scientific device in 2010. Zhang was the first to apply artificial intelligence (AI) algorithm and precision optical imaging system to a device of its kind. He has made a number of technological breakthroughs in automated optical inspection (AOI) technologies since then. In 2016, he spearheaded in the incorporation of CASI Vision, which applies AOI technologies to non-destructive automatic inspection of standardized industrial products. To date, Zhang still serves as a researcher and doctoral supervisor at CASIA. As a scientist and an entrepreneur, he encourages his students to do practical research by focusi
          CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

          CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

          (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference on his way to a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,
            CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

            CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

            (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his colleague at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave u
              CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

              CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

              (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) tests a new generation of OCT equipment at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascu
                CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his partner Dr. Mi Lei in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his doctoral studies
                  CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                  CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                  (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui and his colleagues discuss the research progress of OCT technology at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT te
                    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                    (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference with experts at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012
                      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                      (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui adjusts OCT equipment at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,